Clinical Characteristics of Preterm Neonates with Aggressive Posterior Retinopathy of Prematurity

References

• International Committee for the Classification of Retinopathy of Prematurity. The international classification of retinopathy of prematurity revisited. Arch Ophthalmol. 2005;123(7):991–999. doi:10.1001/archopht.123.7.991
   PubMed Web of Science ®Google Scholar
• Holmstrom G, Broberger U, Thomassen P. Neonatal risk factors for retinopathy of prematurity– a population-based study. Acta Ophthalmol Scand. 1998;76(2):204–207. doi:10.1034/j.1600-0420.1998.760216.x
   Google Scholar
• Shapiro M, Blair M, Gonzalez J. Aggressive posterior retinopathy of prematurity (APROP). In: Andrés Kychenthal B, Paola Dorta S, editors. Retinopathy of Prematurity. Cham: Springer International Publishing AG; 2017:49–70.
   Google Scholar
• Gole G, Ells A, Katz X, et al. The international classification of retinopathy of prematurity revisited. Arch Ophthalmol. 2005;123:991–999.
   Google Scholar
• Vinekar A, Jayadev C, Mangalesh S, et al. Comparing the outcome of single versus multiple session laser photoablation of flat neovascularization in zone 1 aggressive posterior retinopathy of prematurity: a prospective randomized study. Retina. 2015;35(10):2130–2136. doi:10.1097/IAE.0000000000000604
   PubMed Web of Science ®Google Scholar
• Fierson W. American Academy of Pediatrics Section on Ophthalmology, American Academy of Ophthalmology, American Association for Pediatric Ophthalmology and Strabismus, American Academy of Certified Orthoptists. Screening examination of premature infants for retinopathy of prematurity. Pediatrics. 2018;142(6):e20183061. doi:10.1542/peds.2018-3061
   PubMed Web of Science ®Google Scholar
• Good W; Early Treatment for Retinopathy of Prematurity Cooperative Group. Final results of the early treatment for retinopathy of prematurity (ETROP) randomized trial. Trans Am Ophthalmol Soc. 2004;102:233–248.
   PubMedGoogle Scholar
• Hussein M, Coats D, Khan H, et al. Evaluating the association of autonomic drug use to the development and severity of retinopathy of prematurity. J AAPOS. 2014;18(4):332–337. doi:10.1016/j.jaapos.2014.02.012
   PubMed Web of Science ®Google Scholar
• Schmidt B, Roberts RS, Davis P, et al. Caffeine therapy for apnea of prematurity. N Engl J Med. 2006;354(20):2112–2121. doi:10.1056/NEJMoa054065
   PubMed Web of Science ®Google Scholar
• Schmidt B, Roberts RS, Davis P, et al. Long-term effects of caffeine therapy for apnea of prematurity. N Engl J Med. 2007;357(19):1893–1902. doi:10.1056/NEJMoa073679
   PubMed Web of Science ®Google Scholar
• Lunt M, Ragab S, Birch A, et al. Comparison of caffeine-induced changes in cerebral blood flow and middle cerebral artery blood velocity shows that caffeine reduces middle cerebral artery diameter. Physiol Meas. 2004;25(2):467–474. doi:10.1088/0967-3334/25/2/006
   Web of Science ®Google Scholar
• Hoecker C, Nelle M, Beedgen B, et al. Effects of a divided high loading dose of caffeine on circulatory variables in preterm infants. Arch Dis Child Fetal Neonatal Ed. 2006;91(1):F61–F64. doi:10.1136/adc.2005.073866
   PubMed Web of Science ®Google Scholar
• Tracy MB, Klimek J, Hinder M, et al. Does caffeine impair cerebral oxygenation and blood flow velocity in preterm infants? Acta Paediatr. 2010;99(9):1319–1323. doi:10.1111/j.1651-2227.2010.01828.x
   Web of Science ®Google Scholar
• Kearns G, Abdel-Rahman S, Alander S, et al. Developmental pharmacology–drug disposition, action, and therapy in infants and children. N Engl J Med. 2003;349(12):1157–1167. doi:10.1056/NEJMra035092
   PubMed Web of Science ®Google Scholar
• Lotfi K, Grunwald J. The effect of caffeine on the human macular circulation. Invest Ophthalmol Vis Sci. 1991;32(12):3028–3032.
   Web of Science ®Google Scholar
• Terai N, Spoerl E, Pillunat L, et al. The effect of caffeine on retinal vessel diameter in young healthy subjects. Acta Ophthalmol. 2012;90(7):e524–e528. doi:10.1111/j.1755-3768.2012.02486.x
   Web of Science ®Google Scholar
• Darlow B, Hutchinson J, Henderson-Smart D, et al. Prenatal risk factors for severe retinopathy of prematurity among very preterm infants of the Australian and New Zealand neonatal network. Pediatrics. 2005;114(4):990–996. doi:10.1542/peds.2004-1309
   Web of Science ®Google Scholar
• Regev R, Lusky A, Dolfin T, et al. Excess mortality and morbidity among small for- gestational-age premature infants: a population-based study. J Pediatr. 2003;143(2):186–191. doi:10.1067/S0022-3476(03)00181-1
   PubMed Web of Science ®Google Scholar
• Sausgtad O. Update on oxygen free radical disease in neonatology. Curr Opin Obstet Gynecol. 2001;13(2):147–153. doi:10.1097/00001703-200104000-00009
   Web of Science ®Google Scholar
• Misra A, Heckford E, Curley A, et al. Do current retinopathy of prematurity screening guidelines miss the early development of pre-threshold type 1 ROP in small for gestational age neonates? Eye. 2008;22(6):825–829. doi:10.1038/sj.eye.6702728
   PubMed Web of Science ®Google Scholar
• Ahn Y, Hong K, Yum H, et al. Characteristic clinical features associated with aggressive posterior retinopathy of prematurity. Eye. 2017;31(6):924–930. doi:10.1038/eye.2017.18
   Web of Science ®Google Scholar
• Tolsma KW, Allred EN, Chen ML, et al. Neonatal bacteremia and retinopathy of prematurity: the ELGAN Study. Arch Ophthalmol. 2011;129(12):1555–1563. doi:10.1001/archophthalmol.2011.319
   PubMedGoogle Scholar
• Abdel HA, Mohamed GB, Othman MF. Retinopathy of prematurity: a study of incidence and risk factors in NICU of Al-Minya University Hospital in Egypt. J Clin Neonatol. 2012;1(2):76–81. doi:10.4103/2249-4847.96755
   PubMedGoogle Scholar
• Thomas K, Shah PS, Canning R, et al. Retinopathy of prematurity: risk factors and variability in Canadian neonatal intensive care units. J Neonatal Perinatal Med. 2015;8(3):207–214. doi:10.3233/NPM-15814128
   PubMedGoogle Scholar
• Quinn GE, Johnson L, Abbasi S. Onset of retinopathy of prematurity as related to postnatal and postconceptional age. Br J Ophthalmol. 1992;76(5):284–288. doi:10.1136/bjo.76.5.284
   Web of Science ®Google Scholar
• Repka MX, Palmer EA, Tung B; For the Cryotherapy for Retinopathy of Prematurity Cooperative Group. Involution of retinopathy of prematurity. Arch Ophthalmol. 2000;118(5):645–649. doi:10.1001/archopht.118.5.645
   Google Scholar
• Sahinoglu-Keskek N, Akkoyun I, Torer B. Favorable outcomes in the treatment of aggressive posterior retinopathy of prematurity. Eur J Ophthalmol. 2021;31(1):179–183. doi:10.1177/1120672119886989
   Web of Science ®Google Scholar
• Kuint J, Barak M, Morag I, et al. Early treated hypotension and outcome in very low birth weight infants. Neonatology. 2009;95(4):311–316. doi:10.1159/000180113
   PubMed Web of Science ®Google Scholar
• Mizoguchi M, Chu T, Murphy F, et al. Dopamine use is an indicator for the development of threshold retinopathy of prematurity. Br J Ophthalmol. 1999;83(4):425–428. doi:10.1136/bjo.83.4.425
   Web of Science ®Google Scholar
• Chen Z, Jia W, Kaufman PL, et al. Immunohistochemical localization of dopamine-beta-hydroxylase in human and monkey eyes. Curr Eye Res. 1999;18(1):39–48. doi:10.1076/ceyr.18.1.39.5391
   PubMed Web of Science ®Google Scholar
• Wu DM, Kawamura H, Li Q, et al. Dopamine activates ATP-sensitive K+ currents in rat retinal pericytes. Vis Neurosci. 2001;18(6):935. doi:10.1017/S0952523801186104
   Web of Science ®Google Scholar
• Allegaert K, Cossey V, Naulaers G, Vanhole C, Devlieger H, Casteels I. Dopamine is an indicator but not an independent risk factor for grade 3 retinopathy of prematurity in extreme low birthweight infants. Br J Ophthalmol. 2004;88(2):309–310. doi:10.1136/bjo.2003.025395
   Web of Science ®Google Scholar
• Kim SJ, Port AD, Swan R, Campbell JB, Chan RVP, Chiang MF. Retinopathy of prematurity: a review of risk factors and their clinical significance. Surv Ophthalmol. 2018;63(5):618–637.
   PubMed Web of Science ®Google Scholar
• Watts P, Adams GGW, Thomas RM, Bunce C. Intraventricular haemorrhage and stage 3 retinopathy of prematurity. Br J Ophthalmol. 2000;84(6):596–599. doi:10.1136/bjo.84.6.596
   Web of Science ®Google Scholar
• Waheeb S, Alshehri K. Incidence of retinopathy of prematurity at two tertiary centers in Jeddah, Saudi Arabia. Saudi J Ophthalmol. 2016;30(2):109–112. doi:10.1016/j.sjopt.2016.02.006
   PubMedGoogle Scholar
• Yau GS, Lee JW, Tam VT, et al. Incidence and risk factors of retinopathy of prematurity from 2 neonatal intensive care units in a Hong Kong Chinese population. Asia Pac J Ophthalmol. 2016;5(3):185–191. doi:10.1097/APO.0000000000000167
   PubMed Web of Science ®Google Scholar
• Lundgren P, Lundberg L, Hellgren G, et al. Aggressive posterior retinopathy of prematurity is associated with multiple infectious episodes and thrombocytopenia. Neonatology. 2017;111(1):79–85. doi:10.1159/000448161
   Web of Science ®Google Scholar